Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aveo Kidney Cancer Drug May Need More Study, FDA Says
Bloomberg
Tuesday, April 30, 2013 - 9:46am
tags:
kidney cancer, FDA, Aveo Pharmaceuticals, tivozanib
3 Biotech Companies Ripe for a Takeover
Motley Fool
Tuesday, April 30, 2013 - 9:00am
tags:
M&A, biotech, Regeneron, Bayer, Arena Pharmaceuticals, GSK, Theravance
OncoGenex initiates clincal trial of OGX-427
The Fly on the Wall
Tuesday, April 30, 2013 - 8:58am
tags:
OGX-427, OncoGenex, bladder cancer
FDA panel says Allergan's Juvederm data supports product effectiveness
Yahoo/Fly on the Wall
Tuesday, April 30, 2013 - 8:53am
tags:
FDA, Allergan, Juvederm, advisory panels, facial fillers
Merck Says Jury Rules in Its Favor in Fosamax Trial
Bloomberg
Tuesday, April 30, 2013 - 8:49am
tags:
Fosamax, Merck, osteoporosis
Zoetis profit beats Street on strong pet product sales
Reuters
Tuesday, April 30, 2013 - 8:41am
tags:
earnings, Zoetis, animal health
Pfizer Lowers 2013 Forecast After Sales Miss Analyst Estimates
Bloomberg
Tuesday, April 30, 2013 - 8:38am
tags:
earnings, Pfizer
United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy
Seeking Alpha
Tuesday, April 30, 2013 - 8:37am
tags:
United Therapeutics, PAH, pulmonary arterial hypertension, Remodulin, Pluristem Therapeutics
What The Pfizer-Merck Diabetes Deal Teaches About Today's Pharma R&D
Forbes
Tuesday, April 30, 2013 - 8:15am
tags:
Pfizer, Merck, diabetes, ertugliflozin, R&D
Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players
Motley Fool
Monday, April 29, 2013 - 5:24pm
tags:
thyroid cancer, Caprelsa, AstraZeneca, Cometriq, Exelixis, Nexavar, Bayer, ONYX Pharmaceuticals
Novartis Rebuts Government Allegations of Misconduct
Motley Fool
Monday, April 29, 2013 - 1:56pm
tags:
Novartis, Myfortic
MedImmune chief taps top prospects, hunts new biologics deals
Fierce Biotech
Monday, April 29, 2013 - 1:00pm
tags:
MedImmune, R&D
Jury hits Takeda with $6.5M judgment in first Actos liability case
Fierce Pharma
Monday, April 29, 2013 - 12:59pm
tags:
Actos, Takeda, bladder cancer, diabetes
Questcor Pharmaceuticals In Play Ahead Of Earnings Release
Seeking Alpha
Monday, April 29, 2013 - 12:57pm
tags:
earnings, Questcor
Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership
TheStreet.com
Monday, April 29, 2013 - 11:48am
tags:
Merck, Pfizer, Lexicon Pharmaceuticals, diabetes, ertugliflozin, LX4211
Forbes Earnings Preview: Merck
Forbes
Monday, April 29, 2013 - 11:47am
tags:
earnings, Merck
Bayer to buy birth-control devices maker for $1.1 billion
Yahoo/Reuters
Monday, April 29, 2013 - 11:41am
tags:
Bayer, M&A, Conceptus
The Biogen MS Pill: The 'Holy Mother' Of All Drug Launches?
Pharmalot
Monday, April 29, 2013 - 11:40am
tags:
Biogen Idec, Tecfidera, drug launches, MS, multiple sclerosis
Teva Pharmaceuticals Is A Bitter Pill To Swallow
Seeking Alpha
Monday, April 29, 2013 - 11:35am
tags:
Teva
The Compelling Science Behind Synergy
Seeking Alpha
Monday, April 29, 2013 - 11:33am
tags:
Synergy Pharmaceuticals, plecanatide, Ironwood, Linzess

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.